A Prospective, Single-arm, Multi-center Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in RefrActory MetAstatic Gastrointestinal Stromal Tumor
Latest Information Update: 08 Aug 2022
At a glance
- Drugs Dasatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- Acronyms DRAMA-GIST
- 19 Jan 2019 Results (n=58) presented at the 2019 Gastrointestinal Cancers Symposium
- 26 May 2016 New trial record